Sub-Cutaneous Insulin in Hyperglycaemic Emergencies

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Hyperglycaemic emergencies are associated with significant mortality (mortality in Diabetic Ketoacidosis 0.65 - 3.3% and in HyperOsmolar Non-Ketotic Coma 12 -17%). To reduce morbidity and mortality, prompt intervention and coma and close monitoring are essential. The study is designed to investigate whether a simple intervention with a long acting insulin can improve resolution of acidosis and hyperglycaemia, prevent recurrence of ketoacidosis and shorten hospital stay.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Royal Bournemouth Hospital
• Treatments: Insulin Detemir

Criteria

Inclusion Criteria:

• Patients presenting with a diabetic emergency aged 18 and above.

Exclusion Criteria:

• Patients who do not speak English and need a translator.

• Patients under the age of 18 years.

• Patients who are unable to give their consent and who do not have a relative present wiling to give assent.